Health Catalyst, Inc. Financial Ratios — HCAT Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-48.25	-38.39	-29.02	-29.84	-18.99	-58.26
Return on Assets (%)	- -	-56.03	-29.08	-26.14	-21.73	-17.34	-16.25	-8.91	-26.14
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	40.28	46.83	51.37	48.06	48.6	48.21	44.55	45.92	48.75
EBITDA Margin (%)	-54.25	-46.8	-29.46	-40.99	-43.87	-33.2	-19.52	-5.28	2.49
Operating Margin (%)	-62.31	-53.38	-35.41	-50.9	-59.38	-50.68	-33.79	-18.79	-13.74
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-64.32	-55.18	-38.69	-61.54	-66.18	-51.29	-39.8	-22.56	-56.97
Profit Margin (%)	-64.36	-55.06	-38.79	-60.91	-63.33	-49.74	-39.92	-22.67	-57.2
Net Income to Common Margin (%)	-64.36	-55.06	-38.79	-60.91	-63.33	-49.74	-39.92	-22.67	-57.2
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-48.25	-38.39	-29.02	-29.84	-18.99	-58.26

Credit (USD)

Credit Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	13	27	53	195	205	248	249	402	171
ST Debt	2	4	3	3	3	3	3	235	5
LT Debt	10	23	50	193	201	245	246	167	166
Total Debt/EBITDA	-0.32	-0.51	-1.15	-2.52	-1.93	-2.7	-4.31	-24.86	22.08
Net Debt/EBITDA	0.34	0.16	-0.66	-1	0.12	-1.2	-2.11	-8.2	13.21
Total Debt/EBIT	-0.28	-0.45	-0.96	-2.03	-1.42	-1.77	-2.49	-6.98	-4.01
Net Debt/EBIT	0.29	0.14	-0.55	-0.8	0.09	-0.79	-1.22	-2.3	-2.4
EBITDA to Interest Expense	-26.99	-26.03	-13.35	-6.69	-6.13	-12.67	-7.93	-0.95	0.32
EBITDA-CapEx/Interest Expense	-29.27	-27.17	-14.51	-7.47	-6.81	-13.28	-8.25	-1.07	0.25
EBIT to Interest Expense	-31	-29.69	-16.05	-8.31	-8.3	-19.34	-13.72	-3.37	-1.76
Interest Expense	1	2	3	12	17	7	7	17	24
Common Equity/Total Assets	-235.31	-337.7	66.36	47.79	62.74	56.5	52.28	42.52	48.9
Long-Term Debt/Equity (%)	- -	- -	24.85	69.78	38.53	57.54	66.97	45.86	67.47
Long-Term Debt/Capital (%)	-4.25	-6.62	19.68	40.87	27.68	36.34	39.89	21.82	39.77
Long-Term Debt/Total Assets (%)	9.51	20.76	16.49	33.35	24.18	32.51	35.01	19.5	32.99
Total Debt/Equity (%)	-4.87	-7.18	26.25	70.73	39.19	58.35	67.88	110.15	69.67
Total Debt/Capital (%)	-5.11	-7.73	20.79	41.43	28.16	36.85	40.43	52.41	41.06
Total Debt/Total Assets (%)	11.45	24.25	17.42	33.8	24.59	32.96	35.49	46.83	34.07
Net Debt to Equity	5.15	2.22	15.04	27.9	-2.35	25.93	33.18	36.34	41.68
Net Debt/Capital (%)	4.95	2.21	12.82	20.3	-2.3	19.8	23.89	25.63	27.97
EBITDA	-40	-53	-46	-77	-106	-92	-58	-16	8
EBITDA-CapEx	-43	-55	-50	-86	-118	-96	-60	-18	6
Operating Income (Loss)	-46	-60	-55	-96	-144	-140	-100	-58	-43

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.67	0.79	4.73	3.08	4.78	4.41	3.57	1.2	1.07
Current Ratio	2.32	1.6	5.48	3.75	5.46	5.18	4.42	1.43	1.89
Quick Ratio	2.23	1.46	5.31	3.63	5.31	4.99	4.25	1.38	1.73
CFO/Avg Current Liab	- -	-1.11	-0.72	-0.38	-0.26	-0.4	-0.39	0.07	- -
Common Equity/Total Assets	-235.31	-337.7	66.36	47.79	62.74	56.5	52.28	42.52	48.9
Long-Term Debt/Equity (%)	- -	- -	24.85	69.78	38.53	57.54	66.97	45.86	67.47
Long-Term Debt/Capital (%)	-4.25	-6.62	19.68	40.87	27.68	36.34	39.89	21.82	39.77
Long-Term Debt/Total Assets (%)	9.51	20.76	16.49	33.35	24.18	32.51	35.01	19.5	32.99
Total Debt/Equity (%)	-4.87	-7.18	26.25	70.73	39.19	58.35	67.88	110.15	69.67
Total Debt/Capital (%)	-5.11	-7.73	20.79	41.43	28.16	36.85	40.43	52.41	41.06
Total Debt/Total Assets (%)	11.45	24.25	17.42	33.8	24.59	32.96	35.49	46.83	34.07
CFO/Total Liabilities	-9.96	-8.3	-31.64	-8.67	-7.46	-10.78	-9.88	2.95	0.28
CFO/CapEx	-11.01	-17.47	-8.15	-2.9	-1.96	-7.97	-14.05	6.85	0.41
Altman's Z-Score	-5.09	-7.35	5.23	1.45	2.31	-1.39	-1.85	-2.13	-7.22

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	5.03	5.61	4.98	4.98	5.71	5.47	5.22	5.35
Days Sales Outstanding	- -	72.55	65.1	73.32	73.25	63.93	66.76	69.93	68.22
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	45.26	27.73	21.91	24.81	31.38	29.66	18.35	15.34
Accounts Payable Turnover Days	- -	8.07	13.16	16.66	14.71	11.63	12.31	19.89	23.8
Cash Conversion Cycle	- -	64.48	51.93	56.66	58.53	52.3	54.46	50.03	44.42
Inventory to Cash Days	- -	72.55	65.1	73.32	73.25	63.93	66.76	69.93	68.22
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	1,273	1,888	2,085	587	540	453	172
- Cash & Cash Equivalents	23	28	18	92	193	116	106	250	51
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	13	27	53	195	205	248	249	402	171
Enterprise Value	-39	-6	1,097	1,813	1,845	472	471	463	248
Total Capital	-247	-348	253	471	727	673	616	767	417
Total Debt/Capital (%)	-5.11	-7.73	20.79	41.43	28.16	36.85	40.43	52.41	41.06
Total Debt / EV	-0.33	-4.28	0.05	0.11	0.11	0.53	0.53	0.87	0.69
EV/Sales	- -	- -	7.08	9.6	7.62	1.71	1.59	1.51	0.8
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	31.93
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	14.59	9.87
EV/Free Cash Flow to Firm	- -	- -	- -	- -	350.2	- -	- -	13.68	9.22
Diluted Market Cap	- -	- -	650	1,721	1,882	575	522	426	167
Diluted Enterprise Value	-10	-2	685	1,825	1,893	707	665	578	287
EV per Share	- -	- -	29.91	41.79	35.05	8.54	8.08	7.23	3.44
TTM Sales	73	113	155	189	242	276	296	307	311
TTM EBITDA	-40	-53	-46	-77	-106	-92	-58	-16	8
TTM Operating Income	-46	-60	-55	-96	-144	-140	-100	-58	-43
TTM Cash Flow to Firm	-35	-38	-29	-15	-7	-28	-26	32	25
TTM Free Cash Flow to Firm	-32	-36	-25	-6	5	-24	-23	34	27

Multiples (USD)

Valuation Multiples API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-23.03	-100.51	-166.53	-18.64	-17	25.51	66.71
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-39	-6	1,097	1,813	1,845	472	471	463	248
Low Price	- -	- -	26	17.48	35.96	6.4	6.6	5.42	2.02
EV/Sales	- -	- -	7.08	9.6	7.62	1.71	1.59	1.51	0.8
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	31.93
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-11.15	-11.1	-15.65	-6.65	-5.34	-6.64	-1.5
Price/Earnings High	- -	- -	-15.55	-15.66	-18.44	-15.89	-7.58	-9.88	-3
Price/Earnings Low	- -	- -	-8.11	-6.01	-11.15	-2.5	-3.15	-4.69	-0.79
Price/Book Value	- -	- -	6.34	6.84	3.99	1.38	1.47	1.24	0.7
Price/Book Value Average	- -	- -	6.54	5.07	5.09	2.21	1.78	1.35	1.12
Price/Book Value High	- -	- -	9.11	7.16	6	5.29	2.52	2	2.24
Price/Book Value Low	- -	- -	4.75	2.75	3.62	0.83	1.05	0.95	0.59
Price/Tangible Book Value	- -	- -	7.42	27.22	8.43	4	5.25	23.34	-4.2
Price/Tangible Book Value Average	- -	- -	7.65	20.2	10.74	6.4	6.34	25.33	-6.72
Price/Tangible Book Value High	- -	- -	10.67	28.49	12.66	15.3	8.99	37.67	-13.45
Price/Tangible Book Value Low	- -	- -	5.56	10.93	7.65	2.41	3.74	17.9	-3.55
Price/Sales	- -	- -	4.2	9.11	7.78	2.07	1.77	1.39	0.54
Price/Sales Average	- -	- -	4.32	6.76	9.91	3.31	2.13	1.51	0.86
Price/Sales High	- -	- -	6.03	9.54	11.68	7.91	3.03	2.24	1.72
Price/Sales Low	- -	- -	3.14	3.66	7.06	1.24	1.26	1.06	0.45
Price/Cash Flow	- -	- -	-20.21	-65.83	-81.38	-16.19	-15.79	29.23	228.52
Price/Cash Flow Average	- -	- -	-20.82	-48.83	-103.66	-25.92	-19.07	31.72	365.45
Price/Cash Flow High	- -	- -	-29.03	-68.9	-122.21	-61.92	-27.07	47.17	731.47
Price/Cash Flow Low	- -	- -	-15.14	-26.43	-73.85	-9.75	-11.26	22.41	193.15
Price/Free Cash Flow Average	- -	- -	-23.73	-74.56	-212.13	-29.84	-20.53	27.68	106.69
Price/Free Cash Flow High	- -	- -	-33.09	-105.2	-250.08	-71.28	-29.14	41.16	213.54
Price/Free Cash Flow Low	- -	- -	-17.26	-40.36	-151.12	-11.22	-12.12	19.55	56.39
EV/Sales Average	- -	- -	8.69	7.96	11.02	3.88	2.69	2.1	1.27
EV/Sales High	- -	- -	12.02	11.01	12.99	8.61	3.61	2.88	2.16
EV/Sales Low	- -	- -	6.38	4.56	7.87	1.76	1.78	1.63	0.85
EV/EBITDA Average	0.26	0.03	-29.48	-19.43	-25.13	-11.69	-13.75	-39.8	51.02
EV/EBITDA High	0.26	0.03	-40.81	-26.87	-29.61	-25.93	-18.48	-54.59	86.57
EV/EBITDA Low	0.26	0.03	-21.65	-11.13	-17.94	-5.29	-9.13	-30.88	34.29
EV/EBIT Average	0.23	0.03	-24.53	-15.65	-18.57	-7.66	-7.95	-11.18	-9.26
EV/EBIT High	0.23	0.03	-33.96	-21.63	-21.88	-16.99	-10.68	-15.33	-15.71
EV/EBIT Low	0.23	0.03	-18.01	-8.96	-13.25	-3.47	-5.28	-8.67	-6.22
Last Price	- -	- -	34.7	43.53	39.62	10.63	9.26	7.07	2.39
High Price	- -	- -	49.85	45.56	59.5	40.65	15.87	11.41	7.65
Enterprise Value Average	-10	-2	1,346	1,504	2,667	1,072	795	644	396
Enterprise Value High	-10	-2	1,863	2,080	3,142	2,378	1,068	883	671
Enterprise Value Low	-10	-2	988	862	1,903	485	528	500	266

Shares Outstanding	34	34	37	43	53	55	58	64	72
Diluted Weighted Avg Shares	28	28	19	40	47	54	56	60	70
Basic Weighted Avg Shares	28	28	19	40	47	54	56	60	70
Revenue per Share	2.63	4.05	8.27	4.78	5.09	5.14	5.25	5.09	4.45
EBITDA per Share	-1.43	-1.9	-2.44	-1.96	-2.23	-1.71	-1.02	-0.27	0.11
Operating Income per Share	-1.64	-2.16	-2.93	-2.43	-3.02	-2.61	-1.77	-0.96	-0.61
Basic EPS, GAAP	-1.69	-2.23	-3.21	-2.91	-3.23	-2.56	-2.09	-1.15	-2.55
Basic EPS from Cont Ops	-1.69	-2.23	-3.21	-2.91	-3.23	-2.56	-2.09	-1.15	-2.55
Diluted EPS, GAAP	-1.69	-2.23	-3.21	-2.91	-3.23	-2.54	-2.09	-1.15	-2.55
Diluted EPS from Cont Ops	-1.69	-2.23	-3.21	-2.91	-3.23	-2.54	-2.09	-1.15	-2.55
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.33	-1.45	-1.72	-0.66	-0.49	-0.66	-0.59	0.24	0.01
Free Cash Flow per Basic Share	-1.45	-1.53	-1.93	-0.89	-0.74	-0.74	-0.63	0.21	-0.01
Cash & Equivalents per Share	1.51	0.97	6.22	6.24	8.46	6.58	5.45	6.12	1.33
Book Value per Share	-7.61	-11	5.47	6.37	9.92	7.69	6.29	5.7	3.41
Tangible Book Value per Share	-8.59	-11.94	4.67	1.6	4.7	2.66	1.76	0.3	-0.57

Health Catalyst, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)